Skip to content

Adjunctive Benefit of Xenograft Plus a Membrane During Sinus Crestal Approach

Adjunctive Benefit of Xenograft Plus a Membrane During Sinus Crestal Approach

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04662333
Enrollment
36
Registered
2020-12-10
Start date
2020-10-01
Completion date
2023-03-01
Last updated
2020-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edentulous Jaw

Keywords

Dental implant, Sinus lift, maxillary atrophy, biomaterials

Brief summary

Patients in need for implant-supported restoration in maxillary posterior sites with insufficient residual bone height will be randomly allocated to two different arms. Crestal sinus lift with simultaneous implant placement will be performed in both groups. Control group: crestal sinus lift with no adjunctive biomaterial; Test group: crestal sinus lift associated with xenogenic bone graft and collagen membrane; Six months after implant placement, implants will be loaded with definitive screw-retained prostheses. Six months later, patients will be recalled for clinical and radiographic assessment.

Detailed description

Patients in need for implant-supported restoration in maxillary posterior sites with bone deficiencies will be randomly allocated to two different arms. Full-mouth periodontal chart and standardized radiographs will be evaluated at the time of inclusion. Crestal sinus lift with simultaneous implant placement will be performed in both groups. Control group: crestal sinus lift with no adjunctive biomaterial; the healing abutment in this group is made up of PEEK (poly-ether-ether-ketone). Test group: crestal sinus lift associated with xenogenic bone graft and collagen membrane; the healing abutment in this group is made up of titanium; Resonance frequency analysis will be performed at the time of implant placement and at 1, 3, 6 months of follow-up. Both healing abutment will be undersized: this characteristic will allow to harvest a 1mm-wide biopsy of the transmucosal tract at the end of the healing phase (6 months). Six months after implant placement, impression will be taken and implants loaded with definitive screw-retained prostheses. Six months later, patients will be recalled for clinical and radiographic assessment.

Interventions

PROCEDURETranscrestal approach for sinus lift

After surgical exposure of maxillary alveolar crest, implant site preparation and transcrestal detachment of Schneiderian's membrane will be performed. Thereafter implant will be placed, protruding in the maxillary sinus with its apical part.

PROCEDUREXenograft application

Before implant placement, xenogenic collagen membrane and bone granules will be pushed under the Schneiderian's membrane through the surgical site.

Sponsors

University of Siena
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* more than 18 years old * edentulous in posterior maxilla * patient in need of sinus augmentation procedure * residual bone height greater than 3mm

Exclusion criteria

* systemic chronic diseases affecting osseointegration * contraindication for implant therapy * less than 18 years * uncontrolled periodontitis * smoker (more than 10 cig/day)

Design outcomes

Primary

MeasureTime frameDescription
Complications rate12 monthsamount of complications assessed at patient level

Secondary

MeasureTime frameDescription
Peri-implant bone stability12 monthsthe amount (mm) of crestal bone resorption after implant placement assessed through intraoral radiographs
Implant stability quotientbaseline, 1 month, 3 months, 6 monthsimplant stability assessed by resonance frequency analysis
Soft tissue inflammation6 monthspercentage of peri-implant soft tissue affected by inflamed connective tissue

Countries

Italy

Contacts

Primary ContactNicola D Discepoli, Professor
ndiscepoli@me.com3392491188

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026